Sector News

Kraft Heinz to sell part of Indian businesses to drugmaker Zydus: Bloomberg

October 24, 2018
Consumer Packaged Goods

Kraft Heinz Co has agreed to sell a portfolio of its Indian businesses, including children’s drink brand Complan, to Indian drugmaker Zydus Wellness Ltd, Bloomberg reported on Tuesday, citing sources.

The deal with Ahmedabad-based Zydus, which is a unit of Cadila Healthcare Ltd, could be announced as early as this week, the report said, adding that Zydus has been discussing a value of about 46 billion rupees ($625 million) for the businesses.

Earlier this month, the Indian media had reported that Zydus was close to a deal with Kraft Heinz for brands including Glucon-D and Nycil.

Kraft Heinz declined to comment on the report. Cadila Healthcare and Zydus Wellness did not immediately respond to Reuters request for comment.

By Soundarya J

Source: Reuters

comments closed

Related News

March 24, 2024

Aldi’s new flat and stackable wine bottles “make light work of heavy shopping baskets”

Consumer Packaged Goods

Collaborating with Packamama, Aldi has rolled out the “UK’s first” supermarket own-brand flat wine bottles within its Chapter & Verse label. The recyclable ergonomic packaging concept is made from 100% recycled PET (rPET) and available for shiraz and chardonnay options.

March 24, 2024

Health, sustainability, and a taste for adventure drive snacking behaviors: Mondelēz State of Snacking report

Consumer Packaged Goods

For the fifth year in a row, global consumers expressed a preference for snacking over traditional meals, with six in 10 consumers saying they’d rather eat several small meals throughout the day than a few large ones, according to the fifth annual State of Snacking report from Mondelēz International. Nearly nine in 10 (88%) consumers snack daily.

March 24, 2024

Shareholders challenge Nestlé to increase sales of healthy foods

Consumer Packaged Goods

The shareholders are urging Nestlé to set a target to boost the proportion of its sales from healthier products amid concerns regarding regulatory, reputational and legal risks faced by the company, as well as the public health implications “associated with an over-reliance on less healthy foods”.

How can we help you?

We're easy to reach